GB Patent

GB9300125D0 — Compositions containing esters of unsaturated fatty acids

Assigned to Scotia Holdings PLC · Expires 1993-03-03 · 33y expired

What this patent protects

Cholesterol fatty acid esters, where the fatty acid is chosen from an essential fatty acid, or from parinaric or columbinic acids may be used in therapy, especially in the treatment of cancer and cardiovascular disease.

USPTO Abstract

Cholesterol fatty acid esters, where the fatty acid is chosen from an essential fatty acid, or from parinaric or columbinic acids may be used in therapy, especially in the treatment of cancer and cardiovascular disease.

Drugs covered by this patent

Patent Metadata

Patent number
GB9300125D0
Jurisdiction
GB
Classification
—
Expires
1993-03-03
Drug substance claim
No
Drug product claim
No
Assignee
Scotia Holdings PLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.